基于机器学习的anoikis签名预测了乳腺癌的个性化治疗策略
Xiao Guo1, Jiaying Xing1, Yuyan Cao1
1School of Pharmacy, Beihua University, Jilin, China.
Frontiers in immunology
|December 9, 2024
概括
一个新的AI工具,人工智能衍生的Anoikis签名 (AIDAS),准确地预测乳腺癌的结果. 艾达斯识别了与编程细胞死亡相关的基因模式,指导个性化免疫疗法和化疗治疗.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 乳腺癌是全球女性死亡的主要原因之一.
- 有效的预后工具对于改善乳腺癌治疗策略至关重要.
- 阿诺基斯是一种编程细胞死亡形式,对于预防转移至关重要,并影响乳腺癌的进展.
研究的目的:
- 引入人工智能衍生的阿诺基斯签名 (AIDAS),这是乳腺癌的新型预后工具.
- 使用机器学习识别关键的anoikis相关的基因模式.
- 验证AIDAS的可靠性和广泛的临床适用性.
主要方法:
- 使用多队列转录基因数据开发AIDAS.
- 在临床乳腺癌样本上通过免疫组织化学测定验证AIDAS.
- 机器学习算法被用来识别与anoikis相关的基因签名.
主要成果:
- 与现有模型相比,AIDAS在预测乳腺癌结果方面表现出卓越的准确性.
- 低AIDAS水平与免疫疗法 (例如PD-1/PD-L1抑制剂) 的反应增加相关.
- 高AIDAS水平表明对特定化疗剂 (例如甲甲酸盐) 的敏感性更大.
结论:
- 阿诺基斯在乳腺癌预后中起着至关重要的作用.
- 在个性化瘤学中,AIDAS有可能指导个性化治疗策略.
- 通过AIDAS了解阿诺基斯景观可能会导致向治疗和改善患者的治疗结果.
更多相关视频
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
6.7K
09:53Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
7.2K
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
